Current Drug Targets - Cardiovascular & Hematological Disorders

Preface [Hot topic: Insulin Resistance and Impaired Coronary Endothelial Function (Guest Editor: Teruo Inoue)]
pp. i-i(1)
Author: Inoue T.

Molecular Mechanisms of Impaired Endothelial Function Associated with Insulin Resistance
pp. 1-11(11)
Authors: Shinozaki K.; Kashiwagi A.; Masada M.; Okamura T.

Endothelial Dysfunction and Coronary Atherosclerosis
pp. 13-22(10)
Authors: Kitamoto S.; Egashira K.

Endothelial Dysfunction and Coronary Artery Spasm
pp. 23-33(11)
Authors: Kawano H.; Ogawa H.

The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists,PPAR Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells
pp. 35-52(18)
Authors: Inoue I.; Katayama S.

Insulin Resistance as a Therapeutic Target for Improved Endothelial Function:Metformin
pp. 53-63(11)
Authors: Brame L.; Verma S.; Anderson T.; Lteif A.; Mather K.

Microglia:Neuroprotective and Neurotrophic Cells in the Central Nervous System
pp. 65-84(20)
Authors: Nakajima K.; Kohsaka S.

Neuroprotection Abilities of Cytosolic Phospholipase A2 Inhibitors in Kainic acid-induced Neurodegeneration
pp. 85-96(12)
Authors: Farooqui A.A.; Ong W-Y.; Horrocks L.A.

Collagen Cross-link Breakers:A Beginning of a New Era in the Treatment of Cardiovascular Changes Associated with Aging,Diabetes,and Hypertension
pp. 97-101(5)
Authors: Susic D.; Varagic J.; Ahn J.; Frohlich E.D.

Current Understanding of In-stent Restenosis and the Potential Benefit of Drug Eluting Stents
pp. 103-117(15)
Authors: Froeschl M.; Olsen S.; Ma X.; O'Brien E.R.

Author Index to Volume 3
pp. 119-119(1)
Author: Bentham Science Publishers

Subject Index to Volume 3
pp. 121-123(3)
Author: Bentham Science Publishers